Published 2 days ago • loading... • Updated 2 days ago
RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026
Public voting closes Friday as the company cites eight clinical sites and more than 1,500 enrolled patients in its growth-stage expansion.
Charlottesville-based RIVANNA announced yesterday its nomination for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America, with public voting closing Friday, May 8, 2026.
The MedTech Scale-Up of the Year category honors growth-stage companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption across the global medical technology ecosystem.
RIVANNA is backed by 100+ patents and validated through clinical partnerships; its program spans eight sites nationwide with more than 1,500 patients enrolled, supporting an FDA-cleared portfolio for spinal needle guidance and musculoskeletal imaging.
"Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation," said Will Mauldin, PhD, Co-founder and CEO of RIVANNA, ahead of the North American Awards Gala on Monday, May 11, 2026.
Winners across the program's 22 categories are determined by the MedTech World Steering Committee through expert evaluation and public voting, marking the first time the MedTech World Awards are hosted in the United States.